Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

GOP moves to limit abortion pill in US

A House panel advanced a 2024 budget bill that would block the ability to access the abortion drug via telehealth

Salon

Takeaways of AP report on DEA probe of drug distributor accused of fueling opioid epidemic

The U.S. Drug Enforcement Administration has allowed one of the nation’s largest drug distributors to keep shipping addictive painkillers for nearly four years despite a judge’s recommendation to strip its license for turning a blind eye to thousands of suspicious opioid orders

The Independent UK

Invest in These 3 Biotech Stocks Today

With the biotech industry experiencing significant growth due to the increasing demand for healthcare solutions, fundamentally sound stocks such as Amicus Therapeutics (FOLD), POINT Biopharma Global (PNT), and Precision BioSciences (DTIL) might have the potential to provide substantial returns for investors and could be valuable portfolio additions this month. Learn…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson (JNJ) and SNDL Inc. (SNDL) -- Buy or Sell?

Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on.

StockNews.com

Explained | What is the National Medical Devices Policy, 2023?

On April 26, the Union Cabinet approved the National Medical Devices Policy, 2023.Here are the various reasons why it is imporetant

The Hindu

HRT medicine Utrogestan restricted in UK amid shortages

Pharmacists can only dispense maximum of two months’ supply for every prescription as supplier struggles to meet demand

The Guardian - UK

2 Explosive Biotech Stocks to Own

The biotech industry is well-positioned to grow, thanks to breakthrough advances, rising chronic illness and government support. So, fundamentally solid biotech stocks, Genmab (GMAB) and Exelixis (EXEL) may be worth buying now. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Dr. Reddy's Laboratories (RDY) Is the Pharmaceutical Stock to Buy

Dr. Reddy's Laboratories (RDY) delivered exceptional performance, as its fourth-quarter profits grew by an astonishing eleven-fold. By deftly expanding its product line-up and fortifying its market presence, the company sets the stage for significant growth, which could establish it as the go-to pharmaceutical stock to invest in. Read more….

StockNews.com

AstraZeneca China boss pledges to ‘love the Communist Party’

BEIJING: The global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said on Friday.

Bangkok Post

2 Pharma Stocks Investors Are Flocking

The pharmaceutical industry is expected to thrive amid robust demand and government support. Given the solid long-term prospects of the industry, investors should consider buying pharma stocks Ironwood Pharmaceuticals (IRWD) and Calliditas Therapeutics (CALT). Read on.

StockNews.com

2 Pharma Stocks to Watch Like a Hawk

From innovative drug pipelines to innovative research, the pharma sector offers a vast array of investment opportunities. Thus it would be wise to keep an eye on quality stocks Ipsen S.A.(IPSEY) and Kamada (KMDA), which hold considerable potential. Read more….

StockNews.com

How mifepristone became a target of the US anti-abortion movement

The abortion pill, first invented in 1980 in France, was slow to be accepted in the US. Now, it’s at the center of a major court fight

The Guardian - US

Australian pharmacy losses predicted to total $1.2bn over four years under Labor prescription reforms

Government models also outline benefits to patients as guild says changes will send small and regional businesses ‘to the wall’

The Guardian - AU

3 Buy Worthy Biotech Stocks for May

The biotech industry is well-positioned to witness significant growth with government support and breakthrough developments. Therefore, biotech stocks BioNTech SE (BNTX), Acorda Therapeutics (ACOR), and Shionogi (SGIOY) might be solid buys. Read on.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Biotech Stocks Poised to Skyrocket

On the backs of successful trials and breakthrough therapies, the biotech market is poised to thrive. Therefore, scooping up the shares of fundamentally sound biotech stocks such as BioMarin Pharmaceutical (BMRN), Incyte Corp. (INCY), and Innoviva (INVA) could be beneficial. Read more….

Birmingham Post

University of Bristol spin-out secures £415,000 for disease detection tech

Rosa Biotech said it would use the money to accelerate testing of its platform, which acts as a biosensor on patient blood samples

Daily Mirror

Healthcare firm owned by Tory grandee landed £53million in NHS contracts

Tory grandee Lord Ashcroft controlled Medacs Healthcare when it was handed 10 NHS deals worth up to £53million between September 2021 and December 2022, contract notices have revealed

StockNews.com

Best Medical Stock Investors Should Buy in a Recession

Despite the cooling down of inflation, a Fed rate cut is not in sight. Amid recessionary concerns, investing in medical stock Abbott Laboratories (ABT) could be wise given its sound financials and the inherent stability of the medical sector. Let’s take a look at some of the company’s key metrics….

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

2 Pharma Stocks Poised for Record-Breaking Growth

Due to innovative drug development and increasing demand for healthcare, the pharma industry is poised to thrive in the foreseeable future. Given the significant prospects of the industry, pharma stocks Novo Nordisk A/S (NVO) and Novartis AG (NVS) look poised for solid growth and might be ideal additions to one’s…

StockNews.com

Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

The Hindu

DCGI calls for bridging bio-tech interface to get out of generic mindset

Daily Mirror

One of UK's biggest 'Breaking Bad' labs flooded streets with drugs worth £10m a MONTH

John Keet invested profits from a career dealing cocaine, cannabis and amphetamines into building and managing the lab in Henley-in-Arden, a quaint market town in Warwickshire

The Independent UK

Staff shortages force pharmacies to close for 100,000 hours in a year amid plans to give them more work

Exclusive: It comes as experts warn plans to move work from GPs to pharmacies will have ‘marginal’ impact on GP crisis

StockNews.com

3 Growth Stocks to Buy Now

As a slowdown in monetary policy tightening is paving its way, the possibility of a soft landing still stands. Therefore, it could be an ideal opportunity for investors to load up on some fundamentally sound growth stocks, Novartis (NVS), Daimler Truck Holding (DTRUY), and CPI Aerostructures (CVU). Read on….

StockNews.com

2 Most Promising Biotech Stocks to Buy

Given the breakthrough developments and government initiatives, the biotech industry is well-positioned to grow steadily. Therefore, fundamentally strong biotech stocks Amicus Therapeutics (FOLD) and POINT Biopharma (PNT) could be worth buying now. Read on.

1 … 49 50 51 52

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

University of Bristol

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.